Becton, Dickinson and Company (BDX)
| Market Cap | 49.12B |
| Revenue (ttm) | 20.87B |
| Net Income (ttm) | 1.50B |
| Shares Out | 286.61M |
| EPS (ttm) | 5.16 |
| PE Ratio | 33.20 |
| Forward PE | 12.12 |
| Dividend | $4.16 (2.43%) |
| Ex-Dividend Date | Jun 9, 2025 |
| Volume | 1,950,702 |
| Open | 170.51 |
| Previous Close | 172.31 |
| Day's Range | 169.60 - 172.16 |
| 52-Week Range | 163.33 - 251.99 |
| Beta | 0.34 |
| Analysts | Buy |
| Price Target | 235.63 (+37.49%) |
| Earnings Date | May 1, 2025 |
About BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system... [Read more]
Financial Performance
In 2024, BDX's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for BDX stock is "Buy." The 12-month stock price forecast is $235.63, which is an increase of 37.49% from the latest price.
News
Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'
FRANKLIN LAKES, N.J. , May 21, 2025 /PRNewswire/ -- First-of-their-kind studies published in The Lancet Oncology 1 and Cancer Medicine 2 provide new data showing that cancer patients in both hospital ...
35 Barron's Pro-Picks: One Ideal May DiviDog
Barron's interviewed eleven financial industry Roundtable-pros who tapped 65 predictions. Six non-ADR foreign-stocks and four mutual funds were dropped by YCharts screens of active US listings, leavin...
Becton, Dickinson and Company (BDX) Bank of America Securities Health Care Conference - (Transcript)
Becton, Dickinson and Company (NYSE:BDX) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ET Company Participants Tom Polen - Chairman, Chief Executive Officer and Presiden...
BD to Announce Financial Results for its Third Quarter of Fiscal 2025
FRANKLIN LAKES, N.J. , May 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio w...
The Best Health Care Stocks to Buy
The best health care stocks offer investors a defensive hedge in an uncertain market. Here's how to find them.
Buy 3 "Safer" Dividend Kings Of 25 From May's 55
The May collection of Dividend Kings grew to 55, with Automatic Data Processing and RLI Corporation joining, despite two companies dropping off for not increasing dividends. Six top-yield Dividend Kin...
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years
Becton Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday.
Stock Of The Day – Bullish Capitulation In Becton, Dickinson?
Shares of Becton, Dickinson and Company BDX are coming back a little on Friday. This follows Thursday's more than 18% drop.
9 Dividend Aristocrats Potentially Set To Soar, No Matter What Happens Next
I'm going on a 2-week vacation with my family for my sister's wedding, so I've prepared a comprehensive article with three types of dividend aristocrat recommendations for whateveriscomingnext. Low-vo...
Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales
Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its research...
Becton, Dickinson and Company (BDX) Q2 2025 Earnings Call Transcript
Becton, Dickinson and Company (NYSE:BDX) Q2 2025 Results Conference Call May 1, 2025 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer and Head of Investor Relations Tom...
Potential Tariff Bites Into Becton Dickinson 2025 Profit Outlook, Company Will Invest $2.5 Billion To Boost US Manufacturing
Becton, Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday.
Cramer's Stop Trading: Becton Dickinson
CNBC's Jim Cramer explains why he is keeping an eye on shares of Becton Dickinson.
Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit
Medical device maker Becton Dickinson lowered its annual profit forecast on Thursday, in anticipation of a potential hit from U.S. President Donald Trump's tariffs, sending its shares down 5% in prema...
BD Reports Second Quarter Fiscal 2025 Financial Results
Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organic GAAP and adjusted diluted EPS of $1.07 and $3.35, respectively Company updates full-year fiscal 2025 guidance...
BD to Present at Bank of America Securities Health Care Conference
FRANKLIN LAKES, N.J. , April 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of A...
Best Dividend Aristocrats For May 2025
Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Ed...
BD Board Declares Dividend
FRANKLIN LAKES, N.J. , April 29, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has decl...
Becton, Dickinson and Company: It's Wait And See For Me
Becton, Dickinson and Company is a leading medical device firm specializing in medical supplies, devices, laboratory equipment, and diagnostic products. BDX operates in three segments: BD Medical, BD ...
2025 Dividend Kings: Weathering Tariff Volatility Better Than The Market
The Dividend Kings are outperforming the S&P 500 in 2025 by 8.94%. Top performers include National Fuel & Gas (+28.88%), Consolidated Edison (+28.10%), and Middlesex Water Company (+21.00%). Promising...
BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair
Phasix™ ST Umbilical Hernia Patch Leverages Same Surgical Technique as Permanent Mesh Procedures FRANKLIN LAKES, N.J. , April 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), ...
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support
HemoSphere Alta™ Advanced Monitoring Platform with Predictive, Smart Algorithms Helps Clinicians Proactively Address Instability in Blood Flow and Pressure in Critical Situations FRANKLIN LAKES, N.J. ...
DGI For The DIY: 2024 Dividend Portfolio Review
This portfolio focuses on generating a growing stream of dividend income by investing in companies that consistently increase dividends. I reinvest dividends into more shares of the companies I alread...
BD to Announce Financial Results for its Second Quarter of Fiscal 2025
FRANKLIN LAKES, N.J. , April 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio ...
Becton Dickinson in talks to divest life sciences unit, FT reports
Medical device maker Becton Dickinson has begun discussions to sell its life sciences division, valued at $21 billion, and is in talks with competitors such as Thermo Fisher Scientific and Danaher , t...